VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,137,200 | -49.0% | 140,000 | -50.0% | 2.35% | -49.2% |
| Q2 2023 | $13,983,200 | +65.8% | 280,000 | +24.4% | 4.62% | +85.2% |
| Q1 2023 | $8,433,000 | +9.9% | 225,000 | +40.6% | 2.49% | -23.9% |
| Q4 2022 | $7,672,000 | -11.2% | 160,000 | -55.6% | 3.28% | +35.1% |
| Q3 2022 | $8,640,000 | +22.2% | 360,000 | +10.8% | 2.42% | -34.2% |
| Q2 2022 | $7,072,000 | -2.4% | 325,000 | +8.3% | 3.68% | +134.4% |
| Q1 2022 | $7,245,000 | +21.8% | 300,000 | +20.0% | 1.57% | -26.3% |
| Q4 2021 | $5,948,000 | +46.5% | 250,000 | +56.2% | 2.13% | +79.6% |
| Q3 2021 | $4,059,000 | +24.4% | 160,000 | +10.3% | 1.19% | +32.3% |
| Q2 2021 | $3,264,000 | – | 145,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |